28 completed, 5 recruiting, 5 terminated, 4 unknown. 47 Phase 2, 6 Phase 1, 3 Phase 3.
Follow Plaque, Amyloid: new trials by email Literature Review of Plaque, Amyloid trials Research Report on Plaque, Amyloid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AV-1959R Vaccine in Individuals With Preclinical Alzheimer's Disease AV-1959R, Placebo - Preclinical Alzheimer's Disease, Alzheimer Disease | Phase 2 | Not yet recruiting | Institute for Molecular Medicine | 160 | 2027-10-01 | 2026-10-21 |
| Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis IRX4204, Placebo - Psoriasis, Plaque Type Psorisis | Phase 2 | Suspended | Io Therapeutics | 20 | 2027-03-01 | 2026-11-12 |
| A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease GAL-101 Salt, Placebo - Mild to Moderate Alzheimer's Disease | Phase 2 | Not yet recruiting | Galimedix Therapeutics Inc | 100 | 2027-02-28 | 2026-08-27 |
| MCLENA-2: A Phase II Clinical Trial for the Assessment of Lenalidomide in Patients With Mild Cognitive Impairment Lenalidomide 10 mg - Cognitive Impairment, Mild, Cognitive Dysfunction | Phase 2 | Not yet recruiting | St. Joseph's Hospital and Medical Center, Phoenix | 45 | 2025-06-01 | 2025-05-18 |
| A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia. Lemborexant 10 MG, Placebo - Insomnia | Phase 2 | Recruiting | Woolcock Institute of Medical Research | 20 | 2025-05-13 | 2026-09-18 |
| Role of Kefir Mouth Wash in Oral Health Status Amelioration Kefir Mouth Wash, Chlorhexidine 0,12%Biofresh Mouthwash - Plaque Induced Gingivitis, Halitosis | Phase 2 / Phase 3 | Recruiting | Al-Mustansiriyah University | 60 | 2025-04-06 | 2025-04-24 |
| A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMD GAL-101, Placebo - Geographic Atrophy of the Macula | Phase 2 | Recruiting | Galimedix Therapeutics Inc | 110 | 2025-01-10 | 2026-11-10 |
| (Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma Darovasertib - Uveal Melanoma | Phase 2 | Active not recruiting | IDEAYA Biosciences | 160 | 2023-07-03 | 2026-03-16 |
| Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant Xylitol, Placebo - Allogeneic Stem Cell Transplantation | Phase 2 | Terminated | Children's Hospital Medical Center, Cincinnati | 256 | 2023-04-04 | 2026-11-02 |
| A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study) Placebo (Study Part 1a), ACI-24.060 at Dose A in Study Part 1a, ACI-24.060 at Dose B in Study Part 1a - Amyloid Plaque, Beta-Amyloid | Phase 1 / Phase 2 | Recruiting | AC Immune SA | 304 | 2022-06-21 | 2026-07-10 |
| Sleep Trial to Prevent Alzheimer's Disease Suvorexant 20 mg, Placebo - Sleep, Alzheimer Disease | Phase 2 | Recruiting | University of Minnesota | 120 | 2022-05-25 | 2026-07-13 |
| High Dose Risankizumab for Psoriasis risankizumab - Psoriasis | Phase 2 | Completed | Oregon Medical Research Center | 20 | 2022-03-01 | 2025-10-24 |
| Clinical Study of Toothpaste Containing Zinc Lactate as Compared to Colgate Cavity Protection Toothpaste. Meridol, Colgate Cavity Protection - Gingivitis, Plaque | Phase 2 | Completed | Colgate Palmolive | 92 | 2022-01-18 | 2024-08-21 |
| Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease Citalopram 20mg, Placebo - Parkinson Disease | Phase 2 | Completed | University of Michigan | 58 | 2021-04-01 | 2026-03-16 |
| MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients Lenalidomide 10 mg, Placebo - Cognitive Impairment, Mild, Cognitive Dysfunction | Phase 2 | Completed | St. Joseph's Hospital and Medical Center, Phoenix | 15 | 2020-07-22 | 2026-06-10 |
| Modeling the Relationships Between Functional Connectivity and Amyloid Deposition in Alzheimer's Disease F-18-AV45 - Alzheimer's Disease | Phase 2 | Unknown | Chang Gung Memorial Hospital | 300 | 2019-03-28 | 2019-11-22 |
| The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy PMPBB3, AV45 - Vascular Cognitive Impairment, Alzheimer's Disease, Fronto-temporal Dementia | Phase 2 | Unknown | Chang Gung Memorial Hospital | 220 | 2018-09-21 | 2023-05-01 |
| Metagenomic and Metatranscriptomic Analysis of Clinical Plaque Samples Colgate Maximum Cavity Protection plus Sugar Acid Neutralizer, Colgate Cavity Protection - Plaque | Phase 2 | Completed | Colgate Palmolive | 34 | 2017-10-06 | 2021-12-01 |
| Blood Brain Barrier Opening in Alzheimer' Disease SONOCLOUD® - Alzheimer Disease | Phase 1 / Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 10 | 2017-06-26 | 2022-04-12 |
| A Phase 2, Double-blind, Placebo-controlled Study of the Efficacy and Safety of Belumosudil in Subjects With Moderate/Severe Chronic Plaque Psoriasis Belumosudil, Placebo - Chronic Plaque Psoriasis | Phase 2 | Completed | Kadmon Corporation, LLC | 110 | 2016-09-14 | 2022-03-16 |
Showing 20 of 47. Sign in to see all of them.
Alzheimer Disease (17) · Psoriasis (9) · Dementia (4) · Gingivitis (4) · Lymphoma, Follicular (4) · Bronchiolitis Obliterans Syndrome (3) · Cognitive Dysfunction (3) · Pick Disease of the Brain (3) · Skin Diseases (3) · Atherosclerosis (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Coronary Artery Disease (2) · Down Syndrome (2)
Pathological Conditions, Anatomical (47) · Pathological Conditions, Signs and Symptoms (47) · Nervous System Diseases (22) · Brain Diseases (19) · Central Nervous System Diseases (19) · Neurocognitive Disorders (19) · Neurodegenerative Diseases (19) · Mental Disorders (18) · Tauopathies (17) · Dementia (15) · Skin and Connective Tissue Diseases (10) · Skin Diseases, Papulosquamous (8) · Skin Diseases (7) · Stomatognathic Diseases (7) · Pathologic Processes (6)
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (2) · Lenalidomide (2) · Rosuvastatin Calcium (2) · Sugars (2) · florbetapir (2) · secukinumab (2) · 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · AGN 194204 (1) · Capsules (1) · Carnitine (1) · Cellulose (1) · Citalopram (1) · Diffusion Tensor Imaging (1) · Genetic Testing (1) · IRX4204 (1)
Novartis Pharmaceuticals (3) · Chang Gung Memorial Hospital (2) · Colgate Palmolive (2) · Eli Lilly and Company (2) · Galimedix Therapeutics Inc (2) · Instituto Grifols, S.A. (2) · Lantheus Biosciences Ltd. (2) · St. Joseph's Hospital and Medical Center, Phoenix (2) · AC Immune SA (1) · Al-Mustansiriyah University (1) · Assistance Publique - Hôpitaux de Paris (1) · Brigham and Women's Hospital (1) · Children's Hospital Medical Center, Cincinnati (1) · Dr. Amer Johri (1) · Emory University (1)
United States (28) · Germany (6) · Canada (5) · Australia (3) · France (3) · Spain (3) · United Kingdom (3) · Denmark (2) · Israel (2) · Italy (2) · Japan (2) · Netherlands (2) · Taiwan (2) · Armenia (1) · Belgium (1)
Amer M Johri, MD (1) · Andrew Stephens, PhD (1) · Anke Gauliard, MD (1) · Annapoorna Kini, MD (1) · Antonio Paez (1) · Benjamin D Ehst, MD, PhD (1) · Boris Decourt, PhD (1) · Brendan Lucey, MD (1) · Brendon Yee, MBChB, FRACP, FCCP, PhD (1) · Camilla Hoyos, MPH, PhD (1) · Christopher Dandoy, MD, MSc (1)
PMID 33773598, PMID 21481640, PMID 22455413, PMID 22473769, PMID 23686372, PMID 24152824, PMID 25242558, PMID 25669746, PMID 25693783, PMID 27989886, PMID 3425152, PMID 34815790, PMID 35061234, PMID 35260178, PMID 35342978, PMID 35366920, PMID 35867135, PMID 36440097, PMID 3793432, PMID 38489186, PMID 38896380, PMID 39466933, PMID 39910536, PMID 40640892
1UG3DE030401-01 (1), 2016 (1), K01AG047279 (1), R01AG049752 (1), R01AG059008 (1), R01AG065246 (1)